What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.34%Below 5Y avg (1.42%)
Annual Rate
CNY 0.15Paid annual
Payout Ratio
31.3%Sustainable
Last Ex-Dividend
Jun 15, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.97BCNY
444.03M · vs all stocks (USD)
Updated Sep 22, 2026
Trailing P/E
88.10x
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Revenue (TTM)
399.02MCNY
59.56M · vs all stocks (USD)
Updated Sep 22, 2026
Profit Margin
8.19%
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Beta
0.0320x
vs all stocks
Updated Sep 22, 2026
52-Week Change
25.25%
vs all stocks
Updated Sep 22, 2026
Market Capitalization
2.97BCNY
444.03M · vs all stocks (USD)
Updated Sep 22, 2026
Enterprise Value
2.35BCNY
350.95M · vs all stocks (USD)
Updated Sep 22, 2026
Trailing P/E
88.10x
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Forward P/E
43.27x
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Price to Sales (TTM)
7.15x
vs Scientific & Technical Instruments peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 7.45×.Updated Sep 22, 2026
Price to Book (MRQ)
3.54x
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Enterprise to Revenue
5.89x
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Enterprise to EBITDA
55.33x
vs Scientific & Technical Instruments peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 58.99×.Updated Sep 22, 2026
Gross Margin
45.20%
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Profit Margin
8.19%
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Operating Margin
4.62%
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Return on Assets (TTM)
1.97%
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Return on Equity (TTM)
4.07%
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Revenue (TTM)
399.02MCNY
59.56M · vs all stocks (USD)
Updated Sep 22, 2026
Revenue per Share (TTM)
5.88CNYUpdated Sep 22, 2026
Quarterly Revenue Growth
11.00%
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Gross Profit (TTM)
178.66MCNY
26.67M · vs all stocks (USD)
Updated Sep 22, 2026
EBITDA (TTM)
39.86MCNY
5.95M · vs all stocks (USD)
Updated Sep 22, 2026
Net Income (TTM)
32.68MCNY
4.88M · vs all stocks (USD)
Updated Sep 22, 2026
Quarterly Earnings Growth (YoY)
-18.80%
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Operating Cash Flow (TTM)
23.22MCNY
3.47M · vs all stocks (USD)
Updated Sep 22, 2026
Levered Free Cash Flow (TTM)
-13.23MCNY
-1.97M · vs all stocks (USD)
Updated Sep 22, 2026
Trailing Annual Dividend Rate
0.1500CNYUpdated Sep 22, 2026
Trailing Annual Dividend Yield
0.34%
vs all stocks
Updated Sep 22, 2026
5-Year Average Dividend Yield
1.42%
vs all stocks
Updated Sep 22, 2026
Payout Ratio
31.25%
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Revenue
401.08MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
219.38MCNYFY2025 · Dec 31, 2025
Gross Profit
181.70MCNYFY2025 · Dec 31, 2025
Operating Income
41.12MCNY
6.14M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
46.12MCNYFY2025 · Dec 31, 2025
Income Tax Expense
5.73MCNYFY2025 · Dec 31, 2025
Net Income
40.40MCNYFY2025 · Dec 31, 2025
EBIT
46.20MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
64.77MCNYFY2025 · Dec 31, 2025
Research & Development
48.54MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
24.62MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
3.89MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
4.43MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
75.86KCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.6000CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.6000CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
67.33MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
67.33MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
40.40MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
38.60MCNYFY2025 · Dec 31, 2025
Free Cash Flow
33.88MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
258.63MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
40.40MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
-471.24KCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
5.23MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-6.56MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-4.72MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-1.22BCNYFY2025 · Dec 31, 2025
Sale of Investments
1.20BCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-22.79MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-40.07MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-1.05MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-41.12MCNYFY2025 · Dec 31, 2025
Shares Outstanding
67.45MSharesUpdated Sep 22, 2026
Float Shares
26.13MSharesUpdated Sep 22, 2026
% Held by Insiders
67.44%
vs all stocks
Updated Sep 22, 2026
% Held by Institutions
2.02%
vs all stocks
Updated Sep 22, 2026
Total Cash (MRQ)
474.61MCNY
70.85M · vs all stocks (USD)
Updated Sep 22, 2026
Total Cash per Share (MRQ)
7.11CNYUpdated Sep 22, 2026
Total Debt (MRQ)
1.69MCNY
252.02K · vs all stocks (USD)
Updated Sep 22, 2026
Total Debt to Equity (MRQ)
0.0021x
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Current Ratio (MRQ)
7.26x
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Book Value per Share (MRQ)
11.95CNYUpdated Sep 22, 2026
Total Assets
935.40MCNY
139.63M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
765.60MCNYFY2025 · Dec 31, 2025
Total Liabilities
125.13MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
169.80MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
4.10MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
121.03MCNYFY2025 · Dec 31, 2025
Cash
258.63MCNYFY2025 · Dec 31, 2025
Cash Equivalents
3.33MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
261.96MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
258.19MCNYFY2025 · Dec 31, 2025
Accounts Receivable
53.84MCNYFY2025 · Dec 31, 2025
Inventory
176.57MCNYFY2025 · Dec 31, 2025
Accounts Payable
41.74MCNYFY2025 · Dec 31, 2025
Short-term Debt
883.29KCNYFY2025 · Dec 31, 2025
Other Current Liabilities
3.46MCNYFY2025 · Dec 31, 2025
Long-term Debt
945.48KCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
1.52MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
67.45MCNYFY2025 · Dec 31, 2025
Retained Earnings
306.78MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
810.27MCNY
120.95M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
17.01MCNYFY2025 · Dec 31, 2025
52-Week Low
31.01CNYUpdated Sep 22, 2026
52-Week High
82.40CNYUpdated Sep 22, 2026
52-Week Change
25.25%
vs all stocks
Updated Sep 22, 2026
Beta
0.0320x
vs all stocks
Updated Sep 22, 2026
50-Day MA
41.35CNYUpdated Sep 22, 2026
200-Day MA
40.33CNYUpdated Sep 22, 2026
Avg 10-Day Volume
762.08KSharesUpdated Sep 22, 2026
Avg 30-Day Volume
974.52KSharesUpdated Sep 22, 2026
Diluted EPS (TTM)
0.4800CNYUpdated Sep 22, 2026
3 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
Liquidity Ratios Elevated
It can cover near-term bills from cash alone, not just from inventory.
Reads
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Current ratio is 7.26×, higher than 95% of its Scientific & Technical Instruments peers (median 2.38×)Significant
Current ratio: 7.26Industry median: 2.38Industry P95: 7.22Peers compared: 64.00
Debt-to-equity is 0×, lower than 95% of its Scientific & Technical Instruments peers (median 0.13×)Notable
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesLiquidity Ratios ElevatedLow-Leverage Liquidity Configuration
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesLiquidity Ratios ElevatedLow-Leverage Liquidity Configuration